Abuse resistant opioid containing transdermal systems

摘要

The present invention relates to transdermal dosage form ( Fig. 1-3 ) comprising at least one activating agent and at least one inactivating agent. The dosage form ( Fig. 1-3 ) releases the inactivating agent upon disruption of the dosage form ( Fig. 1-3 ) thereby preventing or hindering misuse of the active agent contained in the dosage form ( Fig. 1-3 ).